Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 3.470
+0.090 (2.66%)
Feb 13, 2026, 4:08 PM HKT
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 2.36 billion as of February 13, 2026. Its market cap has increased by 298.73% in one year.
Market Cap
2.36B
Enterprise Value
1.74B
Revenue
92.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.47
Market Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 2.36B, a decrease of -80.70%. That is a compound annual growth rate of -26.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 2.30B | -10.82% |
| Dec 31, 2025 | 2.57B | 482.90% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 3.27B |
| Clover Biopharmaceuticals | 2.93B |
| Jiangsu Recbio Technology | 2.93B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 2.42B |
| SinoMab BioScience | 2.41B |
| Frontage Holdings | 2.07B |
| Mabpharm | 2.06B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.93B |